Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Healthcare Biotechnology

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

Add To Watchlist

TSXV:HEM - Post Discussion

Hemostemix Inc > Hemostemix Inc.'s $HMTXF market cap has broadened.

View:

Post by robert345 on Jun 03, 2022 1:37pm

Hemostemix Inc.'s $HMTXF market cap has broadened.

Hemostemix Inc. (OTC: $HMTXF) is an excellent stock to hold on to as the company is on the verge of completing the phase II clinical trial of its lead product ACP-01 in the United States. The company has a reasonable market cap of 16.27M.

118